Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takako Inoue

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
Clinical Chemistry|July 25, 2015
Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNAJunji Uchida, Kikuya Kato, Yoji Kukita, et al.
Cancer Science|February 9, 2024
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8Yu Mizote, Takako Inoue, Takashi Akazawa, et al.
Cancer Medicine|November 19, 2017
Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancerTakayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya, et al.
Anticancer Research|August 1, 2018
Clinical Characteristics of Liver Metastasis in Nivolumab-treated Patients with Non-small Cell Lung CancerTakayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 9, 2024
Multicenter surveillance of the outcomes of and antimicrobial susceptibility to acute cystitis caused by StaphylococcussaprophyticusToshiki Etani, Shuhei Kondo, Ryohei Azuma, et al.
BMC Cancer|February 13, 2020
A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancerYoshihiro Hattori, Yuko Kono, Shoichi Itoh, et al.
BMC Pulmonary Medicine|December 2, 2023
Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort studyKei Kunimasa, Shingo Matsumoto, Keiichiro Honma, et al.
Immunotherapy|May 25, 2021
Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcomaHayato Kawachi, Kei Kunimasa, Yoji Kukita, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 1, 2026
Clinical Characteristics of Providencia rettgeri Bacteraemia and Antimicrobial Susceptibility PatternsToshiki Etani, Shuhei Kondo, Toshiharu Morikawa, et al.
Cancer Medicine|March 11, 2022
Comparison of sampling methods for next generation sequencing for patients with lung cancerKei Kunimasa, Shingo Matsumoto, Kazumi Nishino, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
Clinical Chemistry|July 25, 2015
Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNAJunji Uchida, Kikuya Kato, Yoji Kukita, et al.
Cancer Science|February 9, 2024
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8Yu Mizote, Takako Inoue, Takashi Akazawa, et al.
Cancer Medicine|November 19, 2017
Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancerTakayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya, et al.
Anticancer Research|August 1, 2018
Clinical Characteristics of Liver Metastasis in Nivolumab-treated Patients with Non-small Cell Lung CancerTakayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 9, 2024
Multicenter surveillance of the outcomes of and antimicrobial susceptibility to acute cystitis caused by StaphylococcussaprophyticusToshiki Etani, Shuhei Kondo, Ryohei Azuma, et al.
BMC Cancer|February 13, 2020
A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancerYoshihiro Hattori, Yuko Kono, Shoichi Itoh, et al.
BMC Pulmonary Medicine|December 2, 2023
Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort studyKei Kunimasa, Shingo Matsumoto, Keiichiro Honma, et al.
Immunotherapy|May 25, 2021
Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcomaHayato Kawachi, Kei Kunimasa, Yoji Kukita, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 1, 2026
Clinical Characteristics of Providencia rettgeri Bacteraemia and Antimicrobial Susceptibility PatternsToshiki Etani, Shuhei Kondo, Toshiharu Morikawa, et al.
Cancer Medicine|March 11, 2022
Comparison of sampling methods for next generation sequencing for patients with lung cancerKei Kunimasa, Shingo Matsumoto, Kazumi Nishino, et al.
Pageof 15